Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

27.44
-0.4600-1.65%
Post-market: 27.500.0599+0.22%19:28 EDT
Volume:7.56M
Turnover:209.49M
Market Cap:6.40B
PE:-44.04
High:28.00
Open:27.30
Low:27.12
Close:27.90
52wk High:65.30
52wk Low:13.74
Shares:233.31M
Float Shares:213.68M
Volume Ratio:0.85
T/O Rate:3.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6230
EPS(LYR):0.5123
ROE:-32.03%
ROA:-2.21%
PB:19.76
PE(LYR):53.56

Loading ...

Hims & Hers Health on FTC Lawsuit : We are Confident in Our Position and Will Vigorously Defend Ourselves Against These Baseless Claims

THOMSON REUTERS
·
Jul 30

Rpt: Hims & Hers on FTC Lawsuit: Lawsuit Disregards Substantial Evidence We Provided the FTC During Its Nearly Three-Year Investigation

THOMSON REUTERS
·
Jul 30

FTC Suing Hims & Hers Health for Allegedly Sending User Info to Meta and Snap, Reuters Reports

MT Newswires Live
·
Jul 30

Hims & Hers Shares Down 12.2%; Reuters Reports US FTC Sues Co for Sending User Health Info to Meta, Snap

THOMSON REUTERS
·
Jul 30

US FTC Suing Hims & Hers for Sending User Health Info to Meta, Snap

Reuters
·
Jul 30

Exclusive - U.S. Federal Trade Commission is Suing Hims & Hers over Billing, Cancellation and Privacy Practices, FTC Spokesperson Says

THOMSON REUTERS
·
Jul 30

Movement Alert|Hims & Hers Health Inc. Falls 5.49% in Regular Trading, Trading at $27.69

Market Focus
·
Jul 29

Hims & Hers Health (HIMS) Receives a Hold from Truist Financial

TIPRANKS
·
Jul 29

Movement Alert|Hims & Hers Health Inc. Falls 5.59% in Regular Trading, Trading at $27.83

Market Focus
·
Jul 28

Movement Alert|Hims & Hers Health Inc. Rises 5.5% in Regular Trading, FDA Advisory Committee Supports Bpc-157 Peptide Compounding Approval

Market Focus
·
Jul 27

Is Today’s Dip a Buying Opportunity for Hims & Hers Health (HIMS) Stock?

TIPRANKS
·
Jul 25

Hims & Hers falls -10.3%

TIPRANKS
·
Jul 25

U.S. Stocks on the Move-booz Allen Hamilton, Sensient, Amkor

Reuters
·
Jul 24

Movement Alert|Hims & Hers Health Inc. Rises 5.04% in Regular Trading, FDA Advisory Committee Backs Bpc-157 Peptide for Pharmacy Compounding

Market Focus
·
Jul 24

Truist Raises Price Target on Hims & Hers Health to $27 From $23, Keeps Hold Rating

MT Newswires Live
·
Jul 24

Hims & Hers Health Inc : Truist Securities Raises Target Price to $27 from $23

THOMSON REUTERS
·
Jul 24

Moderately bullish activity in Hims and Hers Health with shares up 3.39%

TIPRANKS
·
Jul 24

Hims & Hers Health is Maintained at Neutral by Citigroup

Dow Jones
·
Jul 24

FDA Advisers Back First Four of Seven Unapproved Peptides Under Review for Looser Rules

Reuters
·
Jul 24

Why Is Hims & Hers Health Stock Surging on Thursday?

Benzinga
·
Jul 24